• SENSEX
    NIFTY 50
Healthcare

Indian pharma majors deny allegations of price fixing in US

Updated : May 15, 2019 06:47 AM IST

The homegrown drugmakers are among the 21 generic pharmaceutical firms and 15 other individual defendants against whom the Attorneys General of 49 US states, the Commonwealth of Puerto Rico and the District of Columbia had filed a complaint with respect to 116 generic drugs in the US District Court for the District of Connecticut.
The companies have been accused of violating antitrust laws by fixing prices and allocating customers.
Indian pharma majors deny allegations of price fixing in US

You May Also Like

Live TV
Advertisement